bioRxivCell Biology
Global cellular response to chemical perturbation of PLK4 activity and abnormal centrosome number
J. M. Tkach, R. Philip, A. Sharma, J. Strecker, D. Durocher, L. Pelletier
Abstract
Centrosomes act as the main microtubule organizing centre (MTOC) in metazoans. Centrosome number is tightly regulated by limiting centriole duplication to a single round per cell cycle. This control is achieved by multiple mechanisms, including the regulation of the protein kinase PLK4, the most upstream facilitator of centriole duplication. Altered centrosome numbers in mouse and human cells cause p53-dependent growth arrest through poorly defined mechanisms. Recent work has shown that the E3 ligase TRIM37 is required for cell cycle arrest in acentrosomal cells. To gain additional insights into this process, we undertook a series of genome-wide CRISPR/Cas9 screens to identify factors important for growth arrest triggered by treatment with centrinone B, a selective PLK4 inhibitor. We found that TRIM37 is a key mediator of growth arrest after partial or full PLK4 inhibition. Interestingly, PLK4 cellular mobility decreased in a dose-dependent manner after centrinone B treatment. In contrast to recent work, we found that growth arrest after PLK4 inhibition correlated better with PLK4 activity than with mitotic length or centrosome number. These data provide insights into the global response to changes in centrosome number and PLK4 activity and extend the role for TRIM37 in regulating the abundance, localization and function of centrosome proteins.
- organism: mouse
- organism: human
- assay: proteomics
- research focus: cell type annotation
- research focus: cell signaling & trafficking
- research focus: development & morphogenesis
- research focus: cancer & tumor microenvironment
- approach: genetic perturbation / CRISPR
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Use of the Polo-like kinase 4 (PLK4) inhibitor centrinone to investigate intracellular signaling networks using SILAC-based phosphoproteomics
D. P. Byrne, C. J. Clarke, … C. E. Eyers·bioRxiv·May 22, 2020
- Centrosome depletion rewires mitosis to impose dependence on the AURK-TPX2 axis
Zhong Y. Yeow, Fang-Chi Chang, … Andrew Jon Holland·bioRxiv·May 6, 2026
- The CUL4-DDB1-DCAF1 E3 ubiquitin ligase complex regulates PLK4 protein levels to prevent premature centriole duplication
J. Grossmann, A.-S. Kratz, … I. Hoffmann·bioRxiv·Sep 13, 2023
- Prolonged over-expression of PLK4 amplifies centrosomes through formation of inter-connected centrosome rosette clusters
S. C. Ozcan, B. M. Kalkan, … C. Acilan·bioRxiv·Oct 10, 2023
- A dual mechanism of sensitivity to PLK4 inhibition by RP-1664 in neuroblastoma
Isabel Soria‐Bretones, Matias Casás‐Selves, … Michal Zimmermann·bioRxiv·Feb 15, 2025
- Binding of CEP152 to PLK4 stimulates kinase activity to promote centriole assembly
H. Kübra Gürkaşlar, Ingrid Hoffmann·Molecular Biology of the CellPeer-reviewed·May 15, 2025